FI78699C - Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara spiro-imidazolidin-2,2',5-trionderivat. - Google Patents

Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara spiro-imidazolidin-2,2',5-trionderivat. Download PDF

Info

Publication number
FI78699C
FI78699C FI842079A FI842079A FI78699C FI 78699 C FI78699 C FI 78699C FI 842079 A FI842079 A FI 842079A FI 842079 A FI842079 A FI 842079A FI 78699 C FI78699 C FI 78699C
Authority
FI
Finland
Prior art keywords
spiro
imidazolidine
trione
indoline
formula
Prior art date
Application number
FI842079A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI842079A0 (fi
FI78699B (fi
FI842079A7 (fi
Inventor
Alan Jeffrey Hutchison
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI842079A0 publication Critical patent/FI842079A0/fi
Publication of FI842079A7 publication Critical patent/FI842079A7/fi
Priority to FI873628A priority Critical patent/FI81575C/fi
Application granted granted Critical
Publication of FI78699B publication Critical patent/FI78699B/fi
Publication of FI78699C publication Critical patent/FI78699C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • External Artificial Organs (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI842079A 1983-05-25 1984-05-24 Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara spiro-imidazolidin-2,2',5-trionderivat. FI78699C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI873628A FI81575C (fi) 1983-05-25 1987-08-21 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara spiro-imidazolidin-4,3'-azaindolin-2,2',5 -trionderivat.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/497,962 US4464380A (en) 1983-05-25 1983-05-25 Imidazolidinedione derivatives
US49796283 1983-05-25

Publications (4)

Publication Number Publication Date
FI842079A0 FI842079A0 (fi) 1984-05-24
FI842079A7 FI842079A7 (fi) 1984-11-26
FI78699B FI78699B (fi) 1989-05-31
FI78699C true FI78699C (fi) 1989-09-11

Family

ID=23979057

Family Applications (1)

Application Number Title Priority Date Filing Date
FI842079A FI78699C (fi) 1983-05-25 1984-05-24 Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara spiro-imidazolidin-2,2',5-trionderivat.

Country Status (19)

Country Link
US (1) US4464380A (enEXAMPLES)
EP (1) EP0127412B1 (enEXAMPLES)
JP (1) JPS604183A (enEXAMPLES)
KR (1) KR860001869B1 (enEXAMPLES)
AT (1) ATE57531T1 (enEXAMPLES)
AU (1) AU543916B2 (enEXAMPLES)
CA (1) CA1266270A (enEXAMPLES)
DE (1) DE3483402D1 (enEXAMPLES)
DK (1) DK163924C (enEXAMPLES)
ES (2) ES532736A0 (enEXAMPLES)
FI (1) FI78699C (enEXAMPLES)
GR (1) GR82020B (enEXAMPLES)
HU (1) HU190548B (enEXAMPLES)
IE (1) IE57520B1 (enEXAMPLES)
IL (1) IL71904A (enEXAMPLES)
PH (1) PH21151A (enEXAMPLES)
PL (3) PL252850A1 (enEXAMPLES)
PT (1) PT78625A (enEXAMPLES)
YU (2) YU43931B (enEXAMPLES)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3565105D1 (en) * 1984-08-20 1988-10-27 Pfizer Process for the production as asymmetric hydantoins
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
EP0769497B1 (de) * 1995-10-18 2002-12-18 F. Hoffmann-La Roche Ag Hydroxymethylierung von Tocopherolen
DE69925036T2 (de) 1998-12-19 2006-01-26 Janssen Pharmaceutica N.V. Spiro verbindungen mit antihistaminischer aktivität
EP2013216A2 (en) * 2006-02-07 2009-01-14 AstraZeneca AB Novel spiro [imidazolidine-4, 3' -indole] 2, 2', 5' (1h) triones for treatment of conditions associated with vanilloid receptor 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4490381A (en) * 1979-11-13 1984-12-25 Imperial Chemical Industries Plc 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones
ZA806623B (en) * 1979-11-13 1981-12-30 Ici Ltd Substituted indoline-2-one derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives

Also Published As

Publication number Publication date
DK250084A (da) 1984-11-26
IL71904A (en) 1988-01-31
YU89784A (en) 1987-04-30
PT78625A (en) 1984-06-01
EP0127412B1 (en) 1990-10-17
HUT34194A (en) 1985-02-28
IE57520B1 (en) 1993-05-19
AU543916B2 (en) 1985-05-09
GR82020B (enEXAMPLES) 1984-12-12
DK163924C (da) 1992-09-14
YU43958B (en) 1989-12-31
JPS604183A (ja) 1985-01-10
AU2856384A (en) 1984-11-29
JPH0573754B2 (enEXAMPLES) 1993-10-15
KR840009101A (ko) 1984-12-24
EP0127412A2 (en) 1984-12-05
DK163924B (da) 1992-04-21
HU190548B (en) 1986-09-29
YU212286A (en) 1987-10-31
IE841294L (en) 1984-11-25
PL143070B1 (en) 1988-01-30
EP0127412A3 (en) 1987-09-02
ATE57531T1 (de) 1990-11-15
ES540858A0 (es) 1986-06-01
PL247804A1 (en) 1985-08-13
YU43931B (en) 1989-12-31
KR860001869B1 (ko) 1986-10-24
FI842079A0 (fi) 1984-05-24
FI78699B (fi) 1989-05-31
PL252850A1 (en) 1985-11-19
US4464380A (en) 1984-08-07
PL143290B1 (en) 1988-02-29
IL71904A0 (en) 1984-09-30
PH21151A (en) 1987-07-30
FI842079A7 (fi) 1984-11-26
DE3483402D1 (de) 1990-11-22
ES8600764A1 (es) 1985-10-16
ES8607304A1 (es) 1986-06-01
CA1266270A (en) 1990-02-27
DK250084D0 (da) 1984-05-22
ES532736A0 (es) 1985-10-16

Similar Documents

Publication Publication Date Title
AU700637B2 (en) Pyrimidine derivatives as 5ht2c-receptor antagonists
EP0506532B1 (fr) Nouveaux dérivés de l'indole, procédé de préparation et médicaments les contenant
US4233303A (en) Xanthine derivatives
US4248882A (en) Treating diabetes-associated complications with hydantoin amines
JPS6136259A (ja) 新規オキシインドール‐誘導体、その製法及びこれを含有する心蔵及び循環系疾病の治療及び予防剤
EP0446141B1 (fr) Nouveaux dérivés d'imidazo [1,2-C] quinazoline leur procédé de préparation et les compositions pharmaceutiques les renfermant
FI78699C (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara spiro-imidazolidin-2,2',5-trionderivat.
NO812466L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-substituerte benzopyraner
JPS6152834B2 (enEXAMPLES)
LU82584A1 (fr) Nouvelles phenoxyamines heterocycliques substituees,leur methode de preparation et leur application comme anesthesiques locaux
EP0301936B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique
US8188126B2 (en) Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
US3966731A (en) 2-Fluoromethyl-3-o-tolyl-6-amino-4(3H)-quinazolinone
DE69526413T2 (de) Heterocyclische Carboxyalkylderivate
CA1098519A (fr) Hexahydro-benzopyrano ¬3,2-c| pyridines substituees
FI81575C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara spiro-imidazolidin-4,3'-azaindolin-2,2',5 -trionderivat.
US5262422A (en) Octahydrobenzo[g]quinoline
US4193996A (en) Spiro-quinolone hydantoins
JPH0314562A (ja) 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US4533667A (en) Imidazolidinedione derivatives
KR860001870B1 (ko) 이미다졸리딘디온 유도체의 제조방법
FR2609715A1 (fr) Nouveaux diazepinoindoles, leur preparation et leur utilisation comme medicaments
EP1476433B1 (fr) Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments
CZ332195A3 (en) (+)- and (-)-enantiomer of 4-(5-fluoro-2,3-dihydro-1h-inden-2-yl)-1h-imidazole and process for preparing thereof
JPH05170762A (ja) オクタヒドロベンゾ［ｇキノリン

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: PFIZER INC.